C. Eng
Dana-Farber Cancer Institute
Boston
MA 02115-6084
USA
Name/email consistency: low
- Genetic testing: the problems and the promise. Eng, C., Vijg, J. Nat. Biotechnol. (1997)
- The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis. Eng, C., Clayton, D., Schuffenecker, I., Lenoir, G., Cote, G., Gagel, R.F., van Amstel, H.K., Lips, C.J., Nishisho, I., Takai, S.I., Marsh, D.J., Robinson, B.G., Frank-Raue, K., Raue, F., Xue, F., Noll, W.W., Romei, C., Pacini, F., Fink, M., Niederle, B., Zedenius, J., Nordenskjöld, M., Komminoth, P., Hendy, G.N., Mulligan, L.M. JAMA (1996)